Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Nov 18 - Nov 23
CEA was originally described in bile ducts of liver as biliary glycoprotein
Tyramide Signal Amplification (TSA) is an enzymatic detection method that uses horseradish peroxidase (HRP) to label target proteins in situ
K ATPase alpha 1 subunit
which relies on the Tyramide Signal Amplification (TSA) technology
Anti-human Siglec-3 / CD33 (LintuzumAb Biosimilar) Size:1 mg CEA was originally described inApplication ELISA, Bioactivity: FACS, Functional assay, Research in vivo Reactivity Human Target Target Name Siglec 3 CD33 Target Uniprot O14793 Overview Catalog# BIO0405SM Product Name Anti human Siglec 3 CD33 (LintuzumAb Biosimilar) Specifications Conjugation None Clone# LintuzumAb Formulation 100 mM Pro Ac 20mM Arg pH 5. 0 Storage For long term storage, the produce should be stored at 20 or lower. Reconstitution Dissolve with sterile ddH2O
